$0.35
Live
1.34%
Downside
Day's Volatility :6.96%
Upside
5.7%
21.97%
Downside
52 Weeks Volatility :89.71%
Upside
86.82%
Period | Oncology Institute Inc/the | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -29.88% | 3.6% | 0.0% |
6 Months | -67.26% | 10.2% | 0.0% |
1 Year | -75.66% | 19.6% | 0.0% |
3 Years | -96.28% | 16.8% | -23.0% |
Market Capitalization | 26.4M |
Book Value | $0.39 |
Earnings Per Share (EPS) | -0.79 |
Wall Street Target Price | 2.0 |
Profit Margin | -19.81% |
Operating Margin TTM | -16.6% |
Return On Assets TTM | -19.42% |
Return On Equity TTM | -125.59% |
Revenue TTM | 361.1M |
Revenue Per Share TTM | 4.87 |
Quarterly Revenue Growth YOY | 22.900000000000002% |
Gross Profit TTM | 52.1M |
EBITDA | -57.3M |
Diluted Eps TTM | -0.79 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | -0.1 |
EPS Estimate Next Quarter | -0.06 |
What analysts predicted
Upside of 471.43%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 113.2M | - |
Net Income | 3.9M | - |
Net Profit Margin | 3.49% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 155.4M | ↑ 37.33% |
Net Income | -4.0M | ↓ 201.86% |
Net Profit Margin | -2.59% | ↓ 6.08% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 187.5M | ↑ 20.66% |
Net Income | -14.3M | ↑ 256.13% |
Net Profit Margin | -7.64% | ↓ 5.05% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 203.0M | ↑ 8.26% |
Net Income | -10.9M | ↓ 23.7% |
Net Profit Margin | -5.38% | ↑ 2.26% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 252.5M | ↑ 24.37% |
Net Income | 1.7M | ↓ 115.16% |
Net Profit Margin | 0.66% | ↑ 6.04% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 324.2M | ↑ 28.42% |
Net Income | -67.9M | ↓ 4196.38% |
Net Profit Margin | -20.93% | ↓ 21.59% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 76.2M | ↑ 6.68% |
Net Income | -30.0M | ↑ 215.7% |
Net Profit Margin | -39.37% | ↓ 26.07% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 80.2M | ↑ 5.29% |
Net Income | -16.9M | ↓ 43.67% |
Net Profit Margin | -21.06% | ↑ 18.31% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 82.0M | ↑ 2.26% |
Net Income | -17.4M | ↑ 3.09% |
Net Profit Margin | -21.23% | ↓ 0.17% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 85.8M | ↑ 4.57% |
Net Income | -15.3M | ↓ 12.08% |
Net Profit Margin | -17.85% | ↑ 3.38% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 94.7M | ↑ 10.35% |
Net Income | -16.3M | ↑ 6.26% |
Net Profit Margin | -17.19% | ↑ 0.66% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 98.6M | ↑ 4.13% |
Net Income | -12.7M | ↓ 22.08% |
Net Profit Margin | -12.86% | ↑ 4.33% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 59.5M | - |
Total Liabilities | 17.3M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 65.7M | ↑ 10.36% |
Total Liabilities | 37.6M | ↑ 117.29% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 203.4M | ↑ 209.7% |
Total Liabilities | 99.3M | ↑ 164.13% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 263.7M | ↑ 29.65% |
Total Liabilities | 139.1M | ↑ 40.08% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 219.4M | ↓ 16.81% |
Total Liabilities | 162.4M | ↑ 16.77% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 234.6M | ↓ 11.04% |
Total Liabilities | 136.2M | ↓ 2.04% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 230.0M | ↓ 1.99% |
Total Liabilities | 145.2M | ↑ 6.61% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 218.4M | ↓ 5.05% |
Total Liabilities | 146.5M | ↑ 0.87% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 219.4M | ↑ 0.49% |
Total Liabilities | 162.4M | ↑ 10.85% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 204.5M | ↓ 6.78% |
Total Liabilities | 163.2M | ↑ 0.52% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 179.6M | ↓ 12.19% |
Total Liabilities | 150.4M | ↓ 7.87% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.6M | - |
Investing Cash Flow | 2.5M | - |
Financing Cash Flow | -8.2M | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 3.6M | ↓ 35.92% |
Investing Cash Flow | -1.2M | ↓ 148.4% |
Financing Cash Flow | -1.8K | ↓ 99.98% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 508.2K | ↓ 85.94% |
Investing Cash Flow | -8.8M | ↑ 634.22% |
Financing Cash Flow | 11.9M | ↓ 655447.3% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -32.7M | ↓ 6530.05% |
Investing Cash Flow | -230.0M | ↑ 2500.6% |
Financing Cash Flow | 154.0M | ↑ 1195.51% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -61.8M | ↑ 88.97% |
Investing Cash Flow | -131.6M | ↓ 42.78% |
Financing Cash Flow | 92.2M | ↓ 40.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -15.5M | ↑ 10.4% |
Investing Cash Flow | 24.9M | ↓ 176.46% |
Financing Cash Flow | -1.7M | ↑ 101.77% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -8.7M | ↓ 43.96% |
Investing Cash Flow | 24.9M | ↑ 0.0% |
Financing Cash Flow | -2.6M | ↑ 52.19% |
Sell
Neutral
Buy
Oncology Institute Inc/the is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Oncology Institute Inc/the | 27.59% | -67.26% | -75.66% | -96.28% | -96.19% |
Fresenius Medical Care Ag | 1.13% | -0.24% | 18.22% | -43.13% | -40.13% |
Hca Holdings, Inc. | 2.43% | 33.91% | 72.47% | 59.82% | 236.17% |
Tenet Healthcare Corp. | -2.48% | 72.77% | 199.8% | 132.6% | 569.4% |
Universal Health Services Inc. | -1.63% | 46.88% | 89.37% | 72.31% | 62.86% |
Davita Healthcare Partners Inc. | 0.24% | 22.22% | 105.36% | 40.34% | 176.12% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Oncology Institute Inc/the | 47.33 | NA | NA | 0.0 | -1.26 | -0.19 | NA | 0.39 |
Fresenius Medical Care Ag | 20.24 | 20.24 | 0.41 | 2.52 | 0.05 | 0.03 | 0.03 | 47.48 |
Hca Holdings, Inc. | 19.51 | 19.51 | 1.23 | 22.62 | 0.74 | 0.11 | 0.01 | -6.17 |
Tenet Healthcare Corp. | 5.89 | 5.89 | 0.83 | 10.57 | 0.55 | 0.07 | NA | 36.27 |
Universal Health Services Inc. | 17.4 | 17.4 | 1.87 | 15.93 | 0.15 | 0.06 | 0.0 | 97.21 |
Davita Healthcare Partners Inc. | 17.05 | 17.05 | 1.53 | 9.8 | 0.45 | 0.07 | NA | 7.44 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Oncology Institute Inc/the | Buy | $26.4M | -96.19% | 47.33 | -19.81% |
Fresenius Medical Care Ag | Hold | $11.8B | -40.13% | 20.24 | 2.73% |
Hca Holdings, Inc. | Buy | $107.2B | 236.17% | 19.51 | 8.4% |
Tenet Healthcare Corp. | Buy | $15.5B | 569.4% | 5.89 | 13.18% |
Universal Health Services Inc. | Hold | $15.8B | 62.86% | 17.4 | 6.22% |
Davita Healthcare Partners Inc. | Hold | $13.4B | 176.12% | 17.05 | 6.86% |
Insights on Oncology Institute Inc/the
Revenue is up for the last 14 quarters, 48.58M → 98.57M (in $), with an average increase of 5.3% per quarter
Netprofit is up for the last 2 quarters, -16.27M → -12.67M (in $), with an average increase of 28.3% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 200.3% return, outperforming this stock by 276.4%
In the last 3 years, Tenet Healthcare Corp. has given 132.6% return, outperforming this stock by 228.9%
FMR Inc
Deerfield Management Co
Vanguard Group Inc
Kent Lake Capital LLC
Balyasny Asset Management LLC
TIFF Advisory Services Inc
the oncology institute of hope and innovation is a premier cancer treatment center in los angeles. offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, the oncology institute of hope and innovation has 8 southern california locations in the cities of downey, long beach, lynwood, montebello whittier, anaheim, la mirada and glendale. for more information please visit www.theoncologyinstitute.com.
Organization | Oncology Institute Inc/the |
Employees | 800 |
CEO | Mr. Richard Alan Barasch |
Industry | Financial |
Blockchain Coinvestors Acquisition Corp.
$0.35
-5.41%
Granite Ridge Resources Inc
$0.35
-5.41%
Investcorp India Acquisition Corp
$0.35
-5.41%
Angel Oak Financ Strat Inc
$0.35
-5.41%
Lemonade Inc
$0.35
-5.41%
International Money Express
$0.35
-5.41%
Genius Sports Limited
$0.35
-5.41%
Berkshire Hills Bancorp Inc
$0.35
-5.41%
South Plains Financial Inc
$0.35
-5.41%